Artiva Biotherapeutics to Participate in Upcoming Investor Conferences
Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company, announced its participation in upcoming investor conferences.
- TD Cowen's Immunology & Inflammation Summit (Virtual) - fireside chat on November 12, 2025, at 11:30 a.m. ET
- Jefferies Global Healthcare Conference in London - fireside chat on November 18, 2025, at 12:00 p.m. GMT
The management team will be available for investor meetings with registered attendees.
Author's summary: Artiva Biotherapeutics participates in investor conferences.
More News
- Florence + The Machine - Everybody Scream Review
- 'Hotel Transylvania' spinoff 'Motel Transylvania' delayed, now set for 2027 release on Netflix | The Express Tribune
- US Government signs $80bn nuclear deal with Westinghouse, Cameco and Brookfield - Power Technology
- When skeletons come out of the closet and onto the street - Washington Square News
- Shareholders that lost money on Lantheus Holdings, Inc.(LNTH) should contact Levi & Korsinsky about pending Class Action - LNTH
- Sweater Weather: Billboard Crossword (Oct. 30, 2025)
- Revolution in the lighting industry: Scientists create a light as thin as paper and as bright as the sun
- BVP in Development of Two Laurice Molinari Feature Films and One by Robert Homer Mollohan
- Wordle Hints Today: Answer for October 31, 2025
- Quantum Computing Inc. to Host Third Quarter 2025 Shareholder Call on Friday, November 14, 2025